About Urinary Incontinence Slings
Urinary incontinence slings are flexible surgical mesh systems that are placed surgically to restore the urethra to its normal position and efficiently minimize incontinence. A sling procedure uses strips of the body’s tissue or synthetic mesh to create a hammock-like fixture that wraps around the bladder neck and a tube that transports urine from the bladder. Urinary incontinence slings are also called urethral support slings. Urinary slings are of two major types: trans obturator tape sling and tension-free vaginal tape sling. These slings are used in the surgical incontinence for treating stress urinary incontinence.
TechNavio's analysts forecast the Urinary Slings market in the US to grow at a CAGR of 11.85 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Urinary Slings market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of different types of urinary slings. Urinary slings have been segmented into the following:
• Vaginal Slings (TVT, TOT, and Single-incision)
• Male Slings (Artificial Urinary Sphincters)
TechNavio's report, the Urinary Slings Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the landscape of the Urinary Slings market in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Country
• US
Key Vendors
• American Medical System
• Boston Scientific
• Coloplast
• C.R. Bard
• Ethicon (Johnson & Johnson)
Other Prominent Vendor
• Caldera Medical
• Cook Medical
• Covidien
• Organogenesis
• Prosurg
• Sofradim
• Surgicraft
• Uroplasty
Market Driver
• Growing Aging Population
• For a full, detailed list, view our report
Market Challenge
• Risk and Complication Related with Sling Procedures
• For a full, detailed list, view our report
Market Trend
• Demand for Single-incision Slings
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01.Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Indications for Use of Urinary Slings
06.1 Urinary Incontinence
06.2 Types of Urinary Incontinence
06.2.1 Stress Incontinence
06.2.2 Urge Incontinence
06.2.3 Mixed Incontinence
06.2.4 Functional Incontinence
06.2.5 Overflow Incontinence
06.3 Pelvic Organ Prolapse
06.4 Overactive Bladder
06.5 Treatment Techniques for Urinary Incontinence
07. SUI
07.1 Patient Profile
07.2 Treatment Comparison
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by Type
09.1 Vaginal Slings
09.2 Male Slings
09.3 Vaginal Slings Market in US
09.3.1 Market Size and Forecast
09.4 Male Slings Market in US
09.4.1 Market Size and Forecast
10. Vaginal Slings Market in US
10.1 Mid-Urethral Slings
10.2 Single-incision Slings
10.3 TOT Slings Market in US
10.3.1 Market Size and Forecast
10.4 TVT Slings Market in US
10.4.1 Market Size and Forecast
10.5 Single-incision Slings Market in US
10.5.1 Market Size and Forecast
11. Male Slings Market in the US
11.1.1 Market Size and Forecast
12. Reimbursement Scenario
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.2 Market Share Analysis 2014
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 American Medical Systems
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Key Brands
21.1.4 Therapeutic Areas
21.1.5 Geographical Segmentation
21.1.6 Business Strategy
21.1.7 Recent Developments
21.1.8 SWOT Analysis
21.2 Boston Scientific
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Key Products
21.2.4 Key Products in Cardiovascular Segment
21.2.5 Key Products in MedSurg Segment
21.2.6 Key Products in Rhythm Management Segment
21.2.7 Business Segmentation by Revenue 2013
21.2.8 Business Segmentation by Revenue 2012 and 2013
21.2.9 Geographical Segmentation by Revenue 2013
21.2.10 Business Strategy
21.2.11 Recent Developments
21.2.12 SWOT Analysis
21.3 Coloplast
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2014
21.3.4 Business Segmentation by Revenue 2013 and 2014
21.3.5 Geographical Segmentation by Revenue 2014
21.3.6 Business Strategy
21.3.7 Key Developments
21.3.8 SWOT Analysis
21.4 C. R. Bard
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Product Segmentation by Revenue 2013
21.4.4 Product Segmentation by Revenue 2012 and 2013
21.4.5 Geographical Segmentation by Revenue 2013
21.4.6 Business Strategy
21.4.7 Recent Developments
21.4.8 SWOT Analysis
21.5 Johnson & Johnson
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2013
21.5.4 Business Segmentation by Revenue 2012 and 2013
21.5.5 Geographical Segmentation by Revenue 2013
21.5.6 Business Strategy
21.5.7 Recent Developments
21.5.8 SWOT Analysis
22. Other Reports in this Series
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Types of Urinary Incontinence and Prevalence
Exhibit 3: Urinary Slings Market in US 2014-2019 (US$ million)
Exhibit 4: Urinary Slings Segmentation by Type
Exhibit 5: Segmentation of Urinary Slings Market in US by Type 2014
Exhibit 6: Vaginal Slings Market in US 2014-2019 (US$ million)
Exhibit 7: Male Slings Market in US 2014-2019 (US$ million)
Exhibit 8: Segmentation of Urinary Slings Market in US by Type 2014-2019 (US$ million)
Exhibit 9: Segmentation of Urinary Slings Market in US by Gender 2014-2019
Exhibit 10: Segmentation of Urinary Slings Market in US by Type 2014-2019 (US$ million)
Exhibit 11: Segmentation of Urinary Slings Market in the US by Type 2014-2019
Exhibit 12: YOY Growth Rates for Urinary Slings Market in US
Exhibit 13: Segmentation of Vaginal Slings Market in US by Procedure
Exhibit 14: TOT Slings Market in US 2014-2019 (US$ million)
Exhibit 15: TVT Slings Market in US 2014-2019 (US$ million)
Exhibit 16: Single-incision Market in US 2014-2019 (US$ million)
Exhibit 17: Male Slings Market in US 2014-2019 (US$ million)
Exhibit 18: Reimbursement for Slings (Medicare)
Exhibit 19: Slings RVUs (Medicare)
Exhibit 20: ICD Diagnosis Codes for Slings
Exhibit 21: Urinary Incontinence in Women in US 2014
Exhibit 22: Urinary Incontinence in Men in US 2014
Exhibit 23: Per Capita Healthcare Expenditure in Top 10 Countries 2010-2013 (US$)
Exhibit 24: Per Capita Healthcare Expenditure in Top 10 Countries 2010-2013
Exhibit 25: American Medical Systems: Key Brands
Exhibit 26: American Medical Systems: Therapeutic Areas
Exhibit 27: American Medical Systems: Geographical Segmentation
Exhibit 28: Boston Scientific: Key Products in Cardiovascular Segment
Exhibit 29: Boston Scientific: Key Products in MedSurg Segment
Exhibit 30: Boston Scientific: Key Products in Rhythm Management Segment
Exhibit 31: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 32: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 33: Boston Scientific: Geographical Segmentation by Revenue 2013
Exhibit 34: Coloplast: Business Segmentation by Revenue 2014
Exhibit 35: Coloplast: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 36: Coloplast: Geographical Segmentation by Revenue 2014
Exhibit 37: C. R. Bard: Product Segmentation by Revenue 2013
Exhibit 38: C. R. Bard: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 39: C. R. Bard: Geographical Segmentation by Revenue 2013
Exhibit 40: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 41: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 42: Johnson & Johnson: Geographical Segmentation by Revenue 2013